Oral Bacteria in the Bloodstream: Study Flags Dental Source Behind One-Third of Serious Streptococcal Infections

When dentists and physicians warn that an untreated tooth infection can spread beyond the mouth, the warning is often dismissed as an exaggeration. A new study from Japan provides some of the clearest evidence yet that the bacteria harbored in our oral cavity can, and do, escape into the bloodstream and seed dangerous infections elsewhere in the body. In a decade-long analysis of adult patients with viridans group streptococcal bacteremia, researchers at Saga University Hospital found that roughly one in three patients developed a complicated infection, and that the strongest clues pointing toward those complications were surprisingly simple: whether the infection was caught in the community rather than the hospital, whether the bacteria originated from a dental source, and whether the culprit organism belonged to a particular species group known for its abscess-forming tendencies.

Viridans group streptococci are a large collection of related bacterial species that normally live harmlessly in the human mouth, throat, gastrointestinal tract, and genitourinary tract. Unlike their more notorious cousins, Streptococcus pneumoniae or Streptococcus pyogenes, they are typically regarded as low-virulence organisms, so much so that when they appear in a blood culture, clinicians sometimes dismiss the result as contamination from skin flora. Yet these bacteria possess a darker side. They can adhere to damaged or artificial heart valves, form vegetations, and cause infective endocarditis, a life-threatening infection of the heart’s inner lining. They can also travel through the circulation to distant organs and establish metastatic pockets of pus, including abscesses in the abdomen, brain, liver, or deep tissues of the neck. Distinguishing between a transient, benign shower of bacteria and the beginning of a truly invasive infection is one of the persistent diagnostic dilemmas in infectious disease medicine.

The new research, published in BMC Infectious Diseases, set out to resolve that dilemma by identifying which factors, measurable at the bedside, predict when viridans group streptococcal bacteremia will turn complicated. The team conducted a single-center retrospective cohort study at Saga University Hospital, reviewing the records of all adults aged eighteen or older from whom viridans group streptococci were isolated from blood cultures between September 2014 and June 2025. To keep the analysis clean, the investigators excluded patients whose blood cultures grew multiple bacterial species, those who arrived in cardiopulmonary arrest, cases judged to be contamination, and patients transferred from other hospitals whose prior course could not be reliably reconstructed.

The definition of a complicated infection was deliberately strict. Patients were classified as complicated only if they had infective endocarditis or a metastatic pyogenic infection, meaning a pus-forming lesion at a sterile body site other than the blood from which viridans group streptococci were also recovered. This distinction matters because it separates genuine deep-tissue invasion from mere presence of bacteria in the bloodstream. Using multivariable logistic regression, a statistical technique that adjusts for the influence of multiple variables simultaneously, the researchers then identified which patient characteristics independently predicted complicated disease.

The results were striking. Among the 164 patients included in the final cohort, 54, or 33 percent, developed complicated infections. Infective endocarditis was the most frequent complication, accounting for 41 percent of complicated cases, followed by intra-abdominal abscess or peritonitis at 22 percent and deep neck infection at 15 percent. These are not trivial diagnoses. Endocarditis often requires prolonged intravenous antibiotic therapy and sometimes cardiac surgery, while deep neck infections can compromise the airway and demand urgent surgical drainage. The fact that a third of all patients with this supposedly mild bacteremia experienced such outcomes challenges the casual attitude many clinicians take toward viridans streptococci in blood cultures.

Perhaps the most counterintuitive finding concerned mortality. In-hospital death occurred in zero percent of patients with complicated infections compared with five percent of those with uncomplicated bacteremia, a difference that did not reach statistical significance. The authors’ data suggest that complicated infections, while more severe in anatomical extent, were recognized and treated, whereas uncomplicated bacteremia may have included patients with greater underlying frailty. The inflammatory markers told a more expected story: white blood cell counts and C-reactive protein levels were both significantly higher in patients with complicated disease, with white cell counts showing a p-value below 0.0001 and C-reactive protein a p-value of 0.0005. Median age, by contrast, was nearly identical between the two groups, at 68 years for complicated cases and 70 years for uncomplicated ones, indicating that age alone offers clinicians little guidance.

The heart of the study lies in its multivariable analysis, which isolated three independent predictors of complicated infection. Community-acquired bacteremia carried an adjusted odds ratio of 4.89, meaning patients who acquired the infection outside the hospital had nearly five times the odds of developing complications compared with those whose bacteremia was hospital-associated. An odontogenic source, meaning the infection originated in the teeth or surrounding dental structures, carried an adjusted odds ratio of 3.07. And bacteremia caused by the Streptococcus anginosus group, a subset of viridans streptococci infamous for forming abscesses, carried an adjusted odds ratio of 2.87. All three confidence intervals excluded one, indicating the associations were statistically robust rather than products of chance.

Each of these predictors tells a coherent biological story. Community acquisition suggests that infections arising from endogenous reservoirs, particularly the mouth, behave differently from hospital-acquired bloodstream infections, which more often reflect indwelling devices or weakened host defenses. The odontogenic association underscores the central role of oral health: dental caries, periodontal disease, and dental procedures can all breach the mucosal barrier and release oral streptococci into the venous circulation. The Streptococcus anginosus group, which includes Streptococcus anginosus, Streptococcus constellatus, and Streptococcus intermedius, is well known among microbiologists for its capacity to produce abscesses, aided by its production of enzymes and its preference for anaerobic, tissue-damaging environments. When these organisms appear in the blood, they frequently signal that a deep-seated collection of pus already exists somewhere in the body.

The clinical implications of the study are practical and immediate. The authors conclude that community acquisition and S. anginosus group bacteremia should raise suspicion for an odontogenic source, prompting clinicians to pursue early imaging, such as computed tomography of the chest, abdomen, or neck depending on symptoms, and to involve dental specialists promptly. Timely source control, whether through drainage of an abscess, extraction of an infected tooth, or debridement of infected tissue, is a cornerstone of managing complicated bacterial infections, and delays in identifying the source are a well-recognized cause of treatment failure. For patients found to have viridans streptococci in their blood, a careful dental examination may be as important as any antibiotic choice.

Beyond the individual bedside, the findings carry a broader public health message about the systemic consequences of neglected oral disease. The mouth is home to one of the densest microbial communities in the human body, and the boundary between commensal colonization and invasive disease is thinner than commonly appreciated. This study, conducted over nearly eleven years at a single Japanese academic center, adds to a growing body of evidence linking oral health to cardiovascular, metabolic, and infectious outcomes elsewhere in the body. While retrospective single-center designs have inherent limitations, including reliance on documentation practices and the referral patterns of one institution, the consistency and strength of the associations reported here give them credibility. For clinicians, the takeaway is to treat viridans group streptococcal bacteremia with appropriate seriousness, particularly when the patient acquired the infection in the community, the organism belongs to the anginosus group, or no obvious source is apparent. For everyone else, the message is older and simpler: the health of your teeth and gums is not separate from the health of the rest of your body, and the bacteria in an abscessed tooth are only a bloodstream away from the heart.

Subject of Research: Risk factors for complicated viridans group streptococcal bacteremia and the role of odontogenic infection sources in adults

Article Title: Factors associated with complicated viridans group streptococcal bacteremia in adults: impact of oral health

Article References: Minami, K., Matono, T., Oka, Y., Urakami, T., & Aoki, Y. (2026). Factors associated with complicated viridans group streptococcal bacteremia in adults: impact of oral health. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14603-w

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14603-w

Keywords: viridans group streptococci, bacteremia, infective endocarditis, odontogenic infection, Streptococcus anginosus group, oral health, abscess, retrospective cohort study, source control, bloodstream infection, infectious diseases, dental caries